Close monitoring of initial enzyme replacement therapy in a patient with childhood-onset Pompe disease

Engel, 2003, Acid maltase deficiency, 1559 Winkel, 2005, The natural course of non-classic Pompe’s disease; a review of 225 published cases, J. Neurol., 252, 875, 10.1007/s00415-005-0922-9 Wokke, 2008, Clinical features of late-onset Pompe disease: a prospective cohort study, Muscle Nerve, 38, 1236, 10.1002/mus.21025 Schoser, 2008, Therapeutic approaches in glycogen storage disease type II/Pompe Disease, Neurotherapeutics, 5, 569, 10.1016/j.nurt.2008.08.009 Beck, 2009, Alglucosidase alfa: Long term use in the treatment of patients with Pompe disease, Ther. Clin. Risk Manag., 5, 767, 10.2147/TCRM.S5776 Amalfitano, 2001, Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial, Genet. Med., 3, 132 Kishnani, 2007, Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease, Neurology, 68, 99, 10.1212/01.wnl.0000251268.41188.04 Winkel, 2004, Enzyme replacement therapy in late-onset Pompe’s disease: a three-year follow-up, Ann. Neurol., 55, 495, 10.1002/ana.20019 van Capelle, 2008, Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease, Neuromuscul. Disord., 18, 447, 10.1016/j.nmd.2008.04.009 Strothotte, 2010, Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial, J. Neurol., 257, 91, 10.1007/s00415-009-5275-3 doi: http://www.mext.go.jp/component/b_menu/houdou/__icsFiles/afieldfile/2009/10/13/1285568_1.pdf (Ministry of education, culture, sports, science and technology-Japan, Motor fitness of students in 2009, in Japanese) (accessed, April 1, 2011). Geiger, 2007, Six-minute walk test in children and adolescents, J. Pediatr., 150, 395, 10.1016/j.jpeds.2006.12.052 Beenakker, 2005, Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients, Eur. J. Paediatr. Neurol., 9, 387, 10.1016/j.ejpn.2005.06.004 Ishigaki, 2010, High-density areas on muscle CT in childhood-onset Pompe disease are caused by excess calcium accumulation, Acta Neuropathol., 120, 537, 10.1007/s00401-010-0732-8 Bernstein, 2010, Pompe disease: Dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients, Mol. Genet. Metab., 101, 130, 10.1016/j.ymgme.2010.06.003